| Title : Drug Regimen Individualization for Attention-Deficit\/Hyperactivity Disorder: Guidance for Methylphenidate and Dexmethylphenidate Formulations - Patrick_2019_Pharmacotherapy_39_677 |
| Author(s) : Patrick KS , Radke JL , Raymond JR , Koller L , Nguyen LV , Rodriguez W , Straughn AB |
| Ref : Pharmacotherapy , 39 :677 , 2019 |
| Abstract : |
| PubMedSearch : Patrick_2019_Pharmacotherapy_39_677 |
| PubMedID: 30351459 |
| Title : Drug Regimen Individualization for Attention-Deficit\/Hyperactivity Disorder: Guidance for Methylphenidate and Dexmethylphenidate Formulations - Patrick_2019_Pharmacotherapy_39_677 |
| Author(s) : Patrick KS , Radke JL , Raymond JR , Koller L , Nguyen LV , Rodriguez W , Straughn AB |
| Ref : Pharmacotherapy , 39 :677 , 2019 |
| Abstract : |
| PubMedSearch : Patrick_2019_Pharmacotherapy_39_677 |
| PubMedID: 30351459 |
| Title : Drug Regimen Individualization for Attention-Deficit\/Hyperactivity Disorder: Guidance for Methylphenidate and Dexmethylphenidate Formulations - Patrick_2019_Pharmacotherapy_39_677 |
| Author(s) : Patrick KS , Radke JL , Raymond JR , Koller L , Nguyen LV , Rodriguez W , Straughn AB |
| Ref : Pharmacotherapy , 39 :677 , 2019 |
| Abstract : |
| PubMedSearch : Patrick_2019_Pharmacotherapy_39_677 |
| PubMedID: 30351459 |